WVE Wave Life Sciences Ltd.

Ownership history in BB BIOTECH AG  ·  6 quarters on record

This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Wave Life Sciences Ltd. (WVE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.97% (2018 Q4)
Avg. % of fund
1.39%
First filed
2017 Q4
Last filed
2019 Q1
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2019 Q1 UNCHANGED 1,465,002 0% 1.43% $56.9M $38.85
2018 Q4 ADDED 1,465,002 +80,000 +5.8% 1.97% $61.6M $42.04
2018 Q3 ADDED 1,385,002 +247,117 +21.7% 1.83% $69.2M $50.00
2018 Q2 ADDED 1,137,885 +241,789 +27.0% 1.26% $43.5M $38.25
2018 Q1 ADDED 896,096 +40,000 +4.7% 0.99% $35.9M $40.10
2017 Q4 INITIATED 856,096 0.85% $30.0M
% of Fund (quarterly)    WVE price (monthly, adj. close)
← Back to BB BIOTECH AG Holdings